Parliament Question: Targets of biotech Industry

• Parliament Question (Lok Sabha, 02 April 2026) in Ministry of Science & Technology on the targets and trajectory of India's biotech industry, anchored in the National Biotech Development Strategy 2021 and the BioE3 Policy 2024.
• India's bioeconomy crossed USD 150 bn in 2023 (two years ahead of schedule) and reached USD 165.7 bn by end-2024, on a glide-path to USD 300 bn by 2030.
• Relevant for GS-III (Science & Tech, Economy) — links industrial policy, biotech R&D, biomanufacturing and the start-up ecosystem.